Contributions to Economic Analysis, pages 255-270

Investigating Health Outcomes Defined by Multiple Chronic Conditions

Publication typeBook Chapter
Publication date2024-08-27
SJR
CiteScore0.6
Impact factor
ISSN05738555
Mullahy J.
Empirical Economics scimago Q1 wos Q2
2016-06-11 citations by CoLab: 21 Abstract  
Estimation of marginal or partial effects of covariates x on various conditional parameters or functionals is often a main target of applied microeconometric analysis. In the specific context of probit models, estimation of partial effects involving outcome probabilities will often be of interest. Such estimation is straightforward in univariate models, and results covering the case of quadrant probability marginal effects in bivariate probit models for jointly distributed outcomes y have previously been described in the literature. This paper’s goals are to extend Greene’s results to encompass the general $$M\ge 2$$ multivariate probit context for arbitrary orthant probabilities and to extended these results to models that condition on subvectors of y and to multivariate ordered probit data structures. It is suggested that such partial effects are broadly useful in situations, wherein multivariate outcomes are of concern.
Mullahy J.
Stata Journal scimago Q1 wos Q1
2016-03-01 citations by CoLab: 20 Abstract  
In this article, I suggest the utility of fitting multivariate probit models using a chain of bivariate probit estimators. This approach is based on Stata's biprobit and suest commands and is driven by a Mata function, bvpmvp(). I discuss two potential advantages of the approach over the mvprobit command (Cappellari and Jenkins, 2003, Stata Journal 3: 278–294): significant reductions in computation time and essentially unlimited dimensionality of the outcome set. Computation time is reduced because the approach does not rely on simulation methods; unlimited dimensionality arises because only pairs of outcomes are considered at each estimation stage. This approach provides a consistent estimator of all the multivariate probit model's parameters under the same assumptions required for consistent estimation via mvprobit, and simulation exercises I provide suggest no loss of estimator precision relative to mvprobit.
Edwards S.T., Landon B.E.
New England Journal of Medicine scimago Q1 wos Q1
2014-11-26 citations by CoLab: 39 Abstract  
In 2015, the Centers for Medicare and Medicaid Services will introduce a non–visit-based payment for chronic care management. The new policy reflects an investment in primary care that may contribute to the development of a value-oriented health system.
Ward B.W., Schiller J.S.
Preventing chronic disease scimago Q1 wos Q1 Open Access
2013-04-19 citations by CoLab: 373 Abstract  
Preventing and ameliorating chronic conditions has long been a priority in the United States; however, the increasing recognition that people often have multiple chronic conditions (MCC) has added a layer of complexity with which to contend. The objective of this study was to present the prevalence of MCC and the most common MCC dyads/triads by selected demographic characteristics. We used respondent-reported data from the 2010 National Health Interview Survey (NHIS) to study the US adult civilian noninstitutionalized population aged 18 years or older (n = 27,157). We categorized adults as having 0 to 1, 2 to 3, or 4 or more of the following chronic conditions: hypertension, coronary heart disease, stroke, diabetes, cancer, arthritis, hepatitis, weak or failing kidneys, chronic obstructive pulmonary disease, or current asthma. We then generated descriptive estimates and tested for significant differences. Twenty-six percent of adults have MCC; the prevalence of MCC has increased from 21.8% in 2001 to 26.0% in 2010. The prevalence of MCC significantly increased with age, was significantly higher among women than men and among non-Hispanic white and non-Hispanic black adults than Hispanic adults. The most common dyad identified was arthritis and hypertension, and the combination of arthritis, hypertension, and diabetes was the most common triad. The findings of this study contribute information to the field of MCC research. The NHIS can be used to identify population subgroups most likely to have MCC and potentially lead to clinical guidelines for people with more common MCC combinations.
Goodman R.A., Posner S.F., Huang E.S., Parekh A.K., Koh H.K.
Preventing chronic disease scimago Q1 wos Q1 Open Access
2013-04-19 citations by CoLab: 482 Abstract  
We outline a conceptual model for improving understanding of and standardizing approaches to defining, identifying, and using information about chronic conditions in the United States. We illustrate this model’s operation by applying a standard classification scheme for chronic conditions to 5 national-level data systems.
Machlin S.R., Soni A.
Preventing chronic disease scimago Q1 wos Q1 Open Access
2013-04-19 citations by CoLab: 54 Abstract  
The objective of this article is to illustrate the usefulness of Medical Expenditure Panel Survey (MEPS) data for examining variations in medical expenditures for people with multiple chronic conditions (MCC). We analyzed 2009 MEPS data to produce estimates of treated prevalence for MCC and associated medical expenditures for adults in the US civilian noninstitutionalized population (sample = 24,870). We also identified the most common dyad and triad combinations of treated conditions. Approximately one-quarter of civilian US adults were treated for MCCs in 2009; 18.3% were treated for 2 to 3 conditions and 7% were treated for 4 or more conditions. The proportion of adults treated for MCC increased with age. White non-Hispanic adults were most likely and Hispanic and Asian adults were least likely to be treated for MCC. Health care expenditures increased as the number of chronic conditions treated increased. Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated for MCC; diabetes in conjunction with these 2 conditions was a common triad. MEPS has the capacity to produce national estimates of health care expenditures associated with MCC. MEPS data in conjunction with data from other US Department of Health and Human Services sources provide information that can inform policies addressing the complex issue of MCC.
Tinetti M.E., Studenski S.A.
New England Journal of Medicine scimago Q1 wos Q1
2011-06-22 citations by CoLab: 112 Abstract  
The aim of comparative effectiveness research (CER) is to improve the quality, effectiveness, and efficiency of health care and to help patients, health care professionals, and purchasers make informed decisions. CER is moving forward, with recently defined priorities and a newly funded Patient-Centered Outcomes Research Institute, which we hope will survive congressional cost cutting. To achieve its goals, CER must address the population that consumes the most health care: patients with multiple chronic conditions, especially those with combinations of behavioral and physical conditions such as dementia, mental illness, end-stage renal disease, and heart failure. Such patients account for more than . . .
Mullahy J.
Journal of Health Economics scimago Q1 wos Q1
2024-05-01 citations by CoLab: 0 Abstract  
This paper assesses analytical strategies that respect the bounded-count nature of health outcomes encountered often in empirical applications. Absent in the literature is a comprehensive discussion and critique of strategies for analyzing and understanding such data. The paper's goal is to provide an in-depth consideration of prominent issues arising in and strategies for undertaking such analyses, emphasizing the merits and limitations of various analytical tools empirical researchers may contemplate. Three main topics are covered. First, bounded-count health outcomes' measurement properties are reviewed and their implications assessed. Second, issues arising when bounded-count outcomes are the objects of concern in evaluations are described. Third, the (conditional) probability and moment structures of bounded-count outcomes are derived and corresponding specification and estimation strategies presented with particular attention to partial effects. Many questions may be asked of such data in health research and a researcher's choice of analytical method is often consequential.

Top-30

Journals

1
1

Publishers

1
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?